VerifiedBiotechnology Research· Founded 2020

Adela, Inc

Adela’s mission is to develop innovative and accessible technologies that harness biology and change the way we diagnose and treat disease. Adela’s genome-wide methylation enrichment technology was originally developed by Chief Scientific Officer Dr. Daniel De Carvalho, PhD, at University Health Network’s Princess Margaret Cancer Centre. Adela is initially planning to develop the technology for use across the entire cancer continuum—for detection, diagnosis and management of disease.

7-day free trial · no credit card

Foster City, United States71(11 to 50)2020adelabio.com LinkedIn

Verified contacts

49

available on Kipplo

LinkedIn employees

71

11 to 50 range

Open roles

—

no listings

Distinct roles

39

indexed titles

Tech stack

1

tools in use

Monthly traffic

458

organic / mo

Sign up free to see all 49 verified contacts at Adela, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

49 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 49 verified contacts

Top roles at Adela, Inc

39 distinct titles indexed · top 10 shown.

2()
2bioinformatics engineer
2principal scientist
1associate director biostatistics
1bioinformatics scientist
1business analyst lims
1chief operations officer
1clinical trial manager
1co-founder
1co-founder and chief medical officer
+29more titles

Sign up to unlock all 49 contacts at Adela, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 49 verified contacts at Adela, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Adela, Inc | Kipplo Discover